search
Back to results

Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System. (iD-System)

Primary Purpose

Ventricular Fibrillation, Ventricular Tachycardia

Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Internal defibrillation during cardiac surgery, using the iD-system
Sponsored by
SMART Clinical Products BV
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ventricular Fibrillation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All races and ethnicity (>18 years)
  • Written informed consent form (ICF) has to be obtained from the patient.
  • Elective surgery: cardiac surgery on pump (CPB)

    • Coronary artery bypass surgery
    • Heart valve repair and/or replacement

      • Mini sternotomy
      • Median sternotomy
    • Redo surgery

Exclusion Criteria:

  • Patients without cardiopulmonary bypass (referred to as heart-lung machine or pump)
  • Emergency surgery without a sufficient amount of time to explain and ask for ICF

Sites / Locations

  • Ziekenhuis Oost-Limburg

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients with cardiac surgery

Arm Description

All patients undergoing cardiac surgery at the Ziekenhuis Oost-Limburg, meeting all inclusion and no exclusion criteria, are asked to participate in the investigation.

Outcomes

Primary Outcome Measures

Number of Patients With Skin Symptoms
Safety of the iD-system will be evaluated to assess if there are skin symptoms to the electrode by confirming if irritation is visible on the back of the patient after removal of the iD elektrode or not. For the more subjects the irritation will be visible, the worse will be the safety of the iD-elektrode.
Number of Patients With Increased Troponin-t Level Classified as Adverse Event
Safety of the iD-system will be evaluated via troponine measurement to assess myocardial injury. Troponine will be measured at 4, 8, 16, 24 and 36 hours post-surgery and will be reported in ng/L. A significant increase of the troponine value during these different time points indicates myocardial injury. The investigator will evaluate every case to assess if it is an Adverse Event or not.
Number of Patients Where the iD-System TM Fails
Efficacy of the the iD-System will be evaluated to assess a successful restoration of the sinus rythm by counting the number of failed attempts to defibrillate which were attributable to device malfunction. This will be captured by a questionnaire, to be completed by the investigator after the surgery. A maximum of 4 shocks can be applied. If the normal arterial hearth rhythm cannot be restored after 4 shocks with the iD-System, conversion to the conventional system occurs.
Ease of Use of the iD-System as Assessed Via Investigator Questionnaire
Ease of use of the iD-System will be evaluated by a questionnaire, to be completed after the procedure. The following items will be assessed: adherence of the iD-Electrode to the patient's back positioning of the iD-Padde for maximal contact with the heart working length of the following cables: iD-Electrode,iD-Paddle and the iD-SMART Cable The questionnaire will consist of 16 questions, each addressing a specific topic of the ease of use, to be scored by the investigator from 1 to 5. 1= very poor, 2= poor, 3= neutral, 4= sufficient, 5= excellent The higher the total score, the better the outcome of the 'ease of use' evaluation.

Secondary Outcome Measures

Full Information

First Posted
June 17, 2019
Last Updated
January 12, 2021
Sponsor
SMART Clinical Products BV
Collaborators
Ziekenhuis Oost-Limburg
search

1. Study Identification

Unique Protocol Identification Number
NCT04011631
Brief Title
Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System.
Acronym
iD-System
Official Title
The Efficacy and Safety of Internal Defibrillation: Evaluation of the iD-Systemβ„’, One-Handed Disposable Internal Defibrillation System
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
September 3, 2018 (Actual)
Primary Completion Date
May 6, 2019 (Actual)
Study Completion Date
July 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
SMART Clinical Products BV
Collaborators
Ziekenhuis Oost-Limburg

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The main aim is to evaluate the safety and efficacy of the iD-Systemβ„’, One-handed Disposable Internal Defibrillation System The device is made for manual defibrillation during intra-thoracic procedure, by transferring a shock from a defibrillation device to the patient's heart, in combination with the iD-Electrode. The device will be used when the patient reaches a stage of ventricular fibrillation or rapid ventricular tachycardia during cardiac surgery.
Detailed Description
The main aim is to evaluate the safety and efficacy of the iD-Systemβ„’, One-handed Disposable Internal Defibrillation System The device is made for manual defibrillation during intra-thoracic procedure, by transferring a shock from a defibrillation device to the patient's heart, in combination with the iD-Electrode. The device will be used when the patient reaches a stage of ventricular fibrillation or rapid ventricular tachycardia during cardiac surgery. In case ventricular fibrillation occurs and the iD-system is not effective to restore the sinus trythm, the conventional approach with use of the two paddels spoons will be performed immediately. the following will be assessed: Ease of use of the device Safety of the device Efficacy of the device

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ventricular Fibrillation, Ventricular Tachycardia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Prospective interventional study with medical device.
Masking
None (Open Label)
Masking Description
The participants / patients treated in the study are blinded for the sponsor.
Allocation
N/A
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients with cardiac surgery
Arm Type
Experimental
Arm Description
All patients undergoing cardiac surgery at the Ziekenhuis Oost-Limburg, meeting all inclusion and no exclusion criteria, are asked to participate in the investigation.
Intervention Type
Procedure
Intervention Name(s)
Internal defibrillation during cardiac surgery, using the iD-system
Intervention Description
When ventricular fibrillation of ventricular tachycardia occurs during surgery, the iD-Paddle will be applied directly to the heart. A maximum of 4 shocks are delivered to the heart to restore normal sinus rhythm. If 4 shocks are not successful standard operating procedure will be enable conform hospital protocol.
Primary Outcome Measure Information:
Title
Number of Patients With Skin Symptoms
Description
Safety of the iD-system will be evaluated to assess if there are skin symptoms to the electrode by confirming if irritation is visible on the back of the patient after removal of the iD elektrode or not. For the more subjects the irritation will be visible, the worse will be the safety of the iD-elektrode.
Time Frame
During intra-thoracic procedure
Title
Number of Patients With Increased Troponin-t Level Classified as Adverse Event
Description
Safety of the iD-system will be evaluated via troponine measurement to assess myocardial injury. Troponine will be measured at 4, 8, 16, 24 and 36 hours post-surgery and will be reported in ng/L. A significant increase of the troponine value during these different time points indicates myocardial injury. The investigator will evaluate every case to assess if it is an Adverse Event or not.
Time Frame
During intra-thoracic procedure till 36 hours post surgery
Title
Number of Patients Where the iD-System TM Fails
Description
Efficacy of the the iD-System will be evaluated to assess a successful restoration of the sinus rythm by counting the number of failed attempts to defibrillate which were attributable to device malfunction. This will be captured by a questionnaire, to be completed by the investigator after the surgery. A maximum of 4 shocks can be applied. If the normal arterial hearth rhythm cannot be restored after 4 shocks with the iD-System, conversion to the conventional system occurs.
Time Frame
During intra-thoracic procedure
Title
Ease of Use of the iD-System as Assessed Via Investigator Questionnaire
Description
Ease of use of the iD-System will be evaluated by a questionnaire, to be completed after the procedure. The following items will be assessed: adherence of the iD-Electrode to the patient's back positioning of the iD-Padde for maximal contact with the heart working length of the following cables: iD-Electrode,iD-Paddle and the iD-SMART Cable The questionnaire will consist of 16 questions, each addressing a specific topic of the ease of use, to be scored by the investigator from 1 to 5. 1= very poor, 2= poor, 3= neutral, 4= sufficient, 5= excellent The higher the total score, the better the outcome of the 'ease of use' evaluation.
Time Frame
During intra-thoracic procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All races and ethnicity (>18 years) Written informed consent form (ICF) has to be obtained from the patient. Elective surgery: cardiac surgery on pump (CPB) Coronary artery bypass surgery Heart valve repair and/or replacement Mini sternotomy Median sternotomy Redo surgery Exclusion Criteria: Patients without cardiopulmonary bypass (referred to as heart-lung machine or pump) Emergency surgery without a sufficient amount of time to explain and ask for ICF
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
M. Beran, Dr.
Organizational Affiliation
Anesthesiologist
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ziekenhuis Oost-Limburg
City
Genk
ZIP/Postal Code
B3600
Country
Belgium

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System.

We'll reach out to this number within 24 hrs